Published January 1, 2010 | Version v1
Journal article Open

The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-d-glucan in patients without risk factors for invasive fungal infections

  • 1. Erciyes Univ, Fac Med, Dept Infect Dis & Clin Microbiol, TR-38039 Kayseri, Turkey
  • 2. Erciyes Univ, Fac Med, Dept Microbiol & Clin Microbiol, TR-38039 Kayseri, Turkey

Description

The aim of this study was to investigate the interaction between intravenous piperacillin/tazobactam treatment and Aspergillus galactomannan antigen (GM) and 1,3-beta-d-glucan (BDG) test results in patients without known risk factors for invasive fungal infections (IFI).

Files

bib-126e9643-a96f-4714-b8b9-92f46b3bd73d.txt

Files (252 Bytes)

Name Size Download all
md5:c54c38802f275521004d55377975f0ce
252 Bytes Preview Download